| ||||||||||||||
|
|
|||||||||||||
2-Adrenoceptors in the Antihyperalgesic Effect of Oxcarbazepine in a Rat Model of Inflammatory Pain
, BPharm, MSc*
kovi
, MD, PhD
-Petrovi
, BPharm, PhD*
i
, BPharm, PhD*
Prostran, MD, PhD
kovi
, BPharm, MD, PhD
From the *Department of Pharmacology, Faculty of Pharmacy,
Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; and
Medical Military Academy, Belgrade, Serbia.
Address correspondence and reprint requests to Maja A. Tomi
, BPharm, MSc, Department of Pharmacology, Faculty of Pharmacy, Vojvode Stepe 450, POB 146, 11221 Belgrade, Serbia. Address e-mail to majat{at}pharmacy.bg.ac.yu.
Abstract
BACKGROUND: We studied whether peripheral
2-adrenergic receptors are involved in the antihyperalgesic effects of oxcarbazepine by examining the effects of yohimbine (selective
2-adrenoceptor antagonist), BRL 44408 (selective
2A-adrenoceptor antagonist), MK-912 (selective
2C-adrenoceptor antagonist), and clonidine (
2-adrenoceptor agonist) on the antihyperalgesic effect of oxcarbazepine in the rat model of inflammatory pain.
METHODS: Rats were intraplantarly (i.pl.) injected with the proinflammatory compound concanavalin A (Con A). A paw-pressure test was used to determine: 1) the development of hyperalgesia induced by Con A; 2) the effects of oxcarbazepine (i.pl.) on Con A-induced hyperalgesia; and 3) the effects of i.pl. yohimbine, BRL 44408, MK-912 and clonidine on the oxcarbazepine antihyperalgesia.
RESULTS: Both oxcarbazepine (1000–3000 nmol/paw; i.pl.) and clonidine (1.9–7.5 nmol/paw; i.pl.) produced a significant dose-dependent reduction of the paw inflammatory hyperalgesia induced by Con A. Yohimbine (260 and 520 nmol/paw; i.pl.), BRL 44408 (100 and 200 nmol/paw; i.pl.) and MK-912 (10 and 20 nmol/paw; i.pl.) significantly depressed the antihyperalgesic effects of oxcarbazepine (2000 nmol/paw; i.pl.) in a dose-dependent manner. The effects of antagonists were due to local effects since they were not observed after administration into the contralateral hindpaw. Oxcarbazepine and clonidine administered jointly in fixed-dose fractions of the ED50 (1/4, 1/2, and 3/4) caused significant and dose-dependent reduction of hyperalgesia induced by Con A. Isobolographic analysis revealed an additive antihyperalgesic effect.
CONCLUSIONS: Our results indicate that the peripheral
2A and
2C adrenoceptors could be involved in the antihyperalgesic effects of oxcarbazepine in a rat model of inflammatory hyperalgesia.
This article has been cited by other articles:
![]() |
R. M. Stepanovic-Petrovic, M. A. Tomic, S. M. Vuckovic, S. Paranos, N. D. Ugresic, M. S. Prostran, S. Milovanovic, and B. Boskovic The Antinociceptive Effects of Anticonvulsants in a Mouse Visceral Pain Model Anesth. Analg., June 1, 2008; 106(6): 1897 - 1903. [Abstract] [Full Text] [PDF] |
||||
|